Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant co » significant _ (Expand Search), significant factor (Expand Search), significant cause (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant co » significant _ (Expand Search), significant factor (Expand Search), significant cause (Expand Search)
-
1021
-
1022
-
1023
-
1024
-
1025
Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>
Published 2025“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
-
1026
NIE ELISA results.
Published 2025“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
-
1027
Kato Katz and PCR database 12 months collection.
Published 2025“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
-
1028
Master database baseline, 4 weeks and 1 year.
Published 2025“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”
-
1029
-
1030
Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022.
Published 2025Subjects: -
1031
-
1032
-
1033
-
1034
-
1035
-
1036
-
1037
-
1038
-
1039
-
1040
Determination of Cleaved Caspase-3 positive cells in MTA and Harvard treated groups.
Published 2024Subjects: